<html>
<head>PUBMED IDs for AMLC</head>
<body bgcolor='#C5F0F2'><h1>AMLC</h1><a href='https://pubmed.ncbi.nlm.nih.gov/156235/'>Activation of suppressor T cells in human autologous mixed lymphocyte culture.</a> July 1  1979<br><a href='https://pubmed.ncbi.nlm.nih.gov/120954/'>[Growth and development of the immunologic system in children].</a> July 1  1979<br><a href='https://pubmed.ncbi.nlm.nih.gov/156235/'>Activation of suppressor T cells in human autologous mixed lymphocyte culture.</a> July 1  1979<br><a href='https://pubmed.ncbi.nlm.nih.gov/2936704/'>Perturbation of the immune network in herpes gestationis.</a> February 1  1986<br><a href='https://pubmed.ncbi.nlm.nih.gov/2458299/'>Alkali myosin light chains in man are encoded by a multigene family that includes the adult skeletal muscle, the embryonic or atrial, and nonsarcomeric isoforms.</a> June 15  1988<br><a href='https://pubmed.ncbi.nlm.nih.gov/2454242/'>G proteins in clinical medicine.</a> June 15  1988<br><a href='https://pubmed.ncbi.nlm.nih.gov/9616163/'>MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.</a> June 17  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/12070009/'>Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.</a> June 19  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14973498/'>Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia.</a> February 20  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16076867/'>Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.</a> August 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18716133/'>An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.</a> August 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21744003/'>Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).</a> February 24  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24416201/'>Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.</a> September 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24416191/'>Association of the hepatocyte growth factor gene with keratoconus in an Australian population.</a> September 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24923295/'>Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.</a> October 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24923223/'>Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors.</a> September 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25299584/'>The NPM1 mutation type has no impact on survival in cytogenetically normal AML.</a> December 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25523507/'>High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.</a> March 2  2014<br></body></html>
